The Steering Committee regularly select the most relevant and up-to-date publications for rapid review. This includes a brief summary highlighting the key points of the paper and a slide deck going into more detail of the data.
Cytokine Signalling Forum
Latest Podcasts
Author Interview: Professor Roy Fleischmann
Professor Roy Fleishmann, clinical professor of medicine at the University of Texas Southwestern Medical Center.
18th November 2021
Discussing Rheumatology: Herpes Zoster and HBV
Prof Iain McInnes discusses the risk of herpes zoster in RA patients taking biologics and DMARDS. He also discusses reactivation of hepatitis B in patients with RA taking tofacitinib.
31st October 2021
Rheumatology Author Professor Paul Bird: Tofacitinib Effectiveness
Paul Bird, Conjoint Professor at the University of South Wales joins Professor Peter Nash, where he discusses real-world data of tofacitinib therapy in RA
15th October 2021
Discussing Rheumatology: Poor Prognostic Factors, Monotherapy, and Combination Therapy
Prof Iain McInnes discusses poor prognostics factors from the FINCH 3 study, and the effectiveness and persistence of monotherapy and combination therapy from the Australian OPAL study.
23rd September 2021
Rheumatology Author Professor Kurt de Vlam: Pain Improvements
Kurt de Vlam, Professor of Rheumatology at UZ Leuven, Belgium.
10th September 2021
Rheumatology Author Professor Vibeke Strand: Upadacitinib and PROs
Vibeke Strand, Adjunct Clinical Professor in the Division of Immunology/Rheumatology, Biopharmaceutical Consultant at Stanford University School of Medicine.
09th September 2021
